Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Post by Snakebite18on Apr 01, 2020 8:43am
60 Views
Post# 30867441

Forecast

ForecastWhile companies scramble to be first, I personally don't think that's vitally important. Sure in the beginning that stock will probably get all the attention but going forward we're  going to need multiple ways to attack this. There's dozens of pills to cure a headache. The point is they all do one thing, cure a headache. Everyone has there favourites or certain ones they can or cannot take for various reasons.  Obviously different but the same goes here. This is a global problem, so it's all hands on deck. That's one reason you file for patents. They have found a possible vaccination thru there research that works and they want to protect it. Going forward this stock is going to go up and like crazy, probably for a while still, but I think longer term this is a good investment as long as you try not to get greedy with it. 
Bullboard Posts